When was Conifer Point founded?

Conifer Point was founded in 2015 and raised its 1st funding round 1 year after it was founded.

Where is Conifer Point located?

Conifer Point is headquartered in Doylestown, United States.

How many employees does Conifer Point have?

As of Sep 30, 2026, the latest employee count at Conifer Point is 16.

Is Conifer Point a funded company?

Conifer Point is a funded company, having raised an undisclosed amount across 3 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jun 01, 2016.

When was the latest funding round of Conifer Point?

Conifer Point's latest funding was a $***** Grant (prize money) round on Jun 03, 2025, with participation from 1 investor.

Where does Conifer Point rank among its competitors?

Conifer Point ranks 8th amongst 102 active competitors, of which 6 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Conifer Point, which secured $2.64M in Jun, 2025.

Who are the top competitors of Conifer Point?

Conifer Point's top competitors include ConcR, HQS Quantum Simulations and Aganitha. Among them, Conifer Point secured the most recent funding round in June, 2025.

Conifer Point - 2026 Company Profile, Funding & Competitors

Company Details

Developer of new drugs using custom fragment-based drug design software. Services offered include molecular dynamics simulations, quantum mechanical simulations, hot-spot mapping, and water mapping. The pipeline includes renin and DHFR in a hit to lead stage for hypertension and gram-negative bacteria, d-ala-d-ala ligase for tuberculosis and gram-negative bacteria in the hit validation stage, and PD-1 for immuno-oncology in the computational chemistry stage

Key Metrics

Founded Year

2015

Location

Doylestown, United States

Stage

Acquired

Latest Funding Round

Grant (prize money), Jun 03, 2025, $*****

Investors

HHS

Ranked

8^th among 102 active competitors

Employee Count

16 as on Sep 30, 2026

Similar Companies

ConcR & 110 more

Exit Details

Acquired by Lodo Therapeutics (Aug 07, 2020)

View Conifer Point's full profile

Conifer Point got acquired by Lodo Therapeutics on Aug 07, 2020.

Click here to take a look at Conifer Point's acquisition in detail

Conifer Point has raised funding over 3 rounds. Its first funding round was on Jun 01, 2016. Its latest funding round was a Grant (prize money) round on Jun 03, 2025 for $*****. 1 investor participated in its latest round. Conifer Point has 1 institutional investor.

Here is the list of recent funding rounds of Conifer Point:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 03, 2025	4365169	Grant (prize money)	6970833	6033776	2537935	7265123
Jul 01, 2020	6921525	Grant (prize money)	4030269	6460429	4848295	HHS
Jun 01, 2016	3884126	Grant (prize money)	7655958	1347643	6345758	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Conifer Point's funding rounds and investors

Conifer Point's employee count trend

Conifer Point has 16 employees as of Sep 26. Here is Conifer Point's employee count trend over the years:

Uncover Conifer Point's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Conifer Point include ConcR, HQS Quantum Simulations and Aganitha. Here is the list of Top 10 competitors of Conifer Point, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	ConcR 2018, London (United Kingdom), Seed	Provider of a platform predicting therapeutic response and outcome for cancer	$3.07M	Avonmore Developments, Cambridge Angels & 7 others	44/100
2nd	HQS Quantum Simulations 2017, Karlsruhe (Germany), Series A	Developer of quantum simulation software for spectroscopy and related techniques	$16.2M	b2venture, UVC Partners & 10 others	43/100
3rd	Aganitha 2017, Hyderabad (India), Funding Raised	Provider of AI-powered drug discovery and development solutions	-	C-CAMP, Technextchallenge & 1 others	42/100
4th	Cellumen 2004, Pittsburgh (United States), Acquired	Biomarkers, antibodies, assay kits, and reagents for life science research	$12.2M	Novitas Capital, Innovation Works & 2 others	35/100
5th	PointCross 2000, Foster City (United States), Seed	Life science software solutions for clinical data automation and regulatory submissions	$120K	-	33/100
6th	Kinentia Biosciences 2007, Albany (United States), Unfunded	Drug discovery and development services, chemoinformatics, and chemical catalog provider	-	-	28/100
7th	Topos Bio San Francisco (United States), Unfunded	Developer of computational platforms for analyzing intrinsically disordered protein structures	-	-	25/100
8th	Conifer Point 2015, Doylestown (United States), Acquired	Developer of new drugs using custom fragment-based drug design software	-	HHS	25/100
9th	Emergentec 2002, Vienna (Austria), Funding Raised	Computational solutions and consulting for better decision making in biomarker, target and drug development.	-	Europa	25/100
10th	InSilicoMinds 2021, Hyderabad (India), Funding Raised	Provider of AI and advanced modeling and simulation solutions	-	Unusual Innovation	24/100